Seelos Therapeutics (NXE) Q2 2023 Earnings Report
DE:NXE Q2 2023 EPS Results
- Actual EPS
- -EUR 742.79
- Consensus EPS
- -EUR 313.32
- Beat/Miss
- Missed by -EUR 429.47
- One Year Ago EPS
- -EUR 675.26
DE:NXE Q2 2023 Revenue Results
- Actual Revenue
- EUR 295.43K
- Expected Revenue
- EUR 0
- Beat/Miss
- Beat by +EUR 295.43K
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/14/2023
- Time
- TBA
- Conference Call
- Monday, August 14, 2023
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:NXE Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Apr 25, 2025 | 2025 (Q1) | ―- | ― | ― | |
| Aug 02, 2024 | 2024 (Q2) | ―0.11 | -46.42 | 100.23% (+46.53) | |
| Apr 26, 2024 | 2024 (Q1) | -10.41-1.44 | -25.32 | 94.31% (+23.88) | |
| Nov 03, 2023 | 2023 (Q3) | -1.59-3.17 | -4.75 | 33.33% (+1.58) | |
| Aug 14, 2023 | 2023 (Q2) | -313.32-742.79 | -675.26 | -10.00% (-67.53) | |
| May 15, 2023 | 2023 (Q1) | -370.89-405.16 | -438.92 | 7.69% (+33.76) | |
| Mar 03, 2023 | 2022 (Q4) | -0.15-0.15 | -0.23 | 34.62% (+0.08) | |
| Nov 04, 2022 | 2022 (Q3) | -0.16-0.16 | -0.1 | -63.64% (-0.06) | |
| Aug 05, 2022 | 2022 (Q2) | -0.18-0.18 | -0.09 | -100.00% (-0.09) | |
| Mar 04, 2022 | 2021 (Q4) | -371.40-877.84 | -405.16 | -116.67% (-472.69) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed